These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 16617400

  • 1. [Procollagen-I, collagen telopeptide I, CEA, CA 15-3 as compared to bone scintigraphy in patients with breast cancer].
    Zissimopoulos A, Petrakis G, Stellos K, Baziotis N.
    Hell J Nucl Med; 2006; 9(1):60-4. PubMed ID: 16617400
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R, Thölix E.
    Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
    [Abstract] [Full Text] [Related]

  • 6. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer.
    Keskikuru R, Kataja V, Kosma VM, Eskelinen M, Uusitupa M, Johansson R, Risteli L, Risteli J, Jukkola A.
    Anticancer Res; 1999; 19(5C):4481-4. PubMed ID: 10650796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
    Imai T, Honda M, Maeda S, Hosoya Y, Arai T, Sumi S, Umeda H, Yano M, Koga F, Arai K, Yoshida K.
    Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
    [Abstract] [Full Text] [Related]

  • 11. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
    Kylmälä T, Tammela TL, Risteli L, Risteli J, Kontturi M, Elomaa I.
    Br J Cancer; 1995 May; 71(5):1061-4. PubMed ID: 7734300
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinoma.
    Hosoya Y, Arai K, Honda M, Sumi S, Yoshida K.
    Eur Urol; 1997 May; 31(2):220-3. PubMed ID: 9076470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of bone scintigraphy with serum tumor markers of CA 15-3 and carcinoembryonic antigen in patients with breast carcinoma.
    Gedik GK, Kiratli PO, Tascioglu B, Aras T.
    Saudi Med J; 2006 Mar; 27(3):317-22. PubMed ID: 16532090
    [Abstract] [Full Text] [Related]

  • 15. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.
    Ueno T, Hashimoto O, Sugawara H, Ogata R, Kusaba N, Torimura T, Sata M, Tanikawa K.
    Int J Oncol; 1998 Aug; 13(2):297-303. PubMed ID: 9664125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
    Tanaka K, Shiraishi K, Sakamoto A, Jojima H, Masuchi K, Okubo Y, Tanaka M, Fuzimatsu Y, Fukahori S, Osabe S, Imamura Y, Honda J, Oizumi K.
    Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
    [Abstract] [Full Text] [Related]

  • 18. Relationship between bone scintigraphy and tumor markers in patients with breast cancer.
    Yildiz M, Oral B, Bozkurt M, Cobaner A.
    Ann Nucl Med; 2004 Sep; 18(6):501-5. PubMed ID: 15515750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer.
    Noguchi M, Yahara J, Noda S.
    Urology; 2003 May; 61(5):993-8. PubMed ID: 12736022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.